The Valley Desk

NCT01964430 · Interventional trial

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Overall registry status Completed

Phase 3

Conditions Antimetabolites, Antineoplastic, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Gemcitabine, Neoplasms, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov